PMCB
PharmaCyte Biotech, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.49
−0.98%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-58.3%
Return on equity
-41.5%
Return on assets
-20.6%
Return on invested capital
0.00x
Asset turnover
-$5.2M
Cash from operations
$3.45
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Apr 1, 2026